Abstract:The focus of this research is in the area of medical device registration and market access in China. Such a study is important as China is one of the largest markets for medical devices in the world making it an important strategic target market for medical devices manufacturers. There were four research questions to be addressed 1) What is the current economic environment for medical devices in China? What are the projections for the future state? 2) What has changed in the medical device regulations in China, with the updated regulations enforced in 2014? 3) What is the impact and challenges to product registration and market access in China? 4) What can the regulatory function do to ensure they create a successful regulatory strategy for Class II and Class III device approval in China that will aid market access? This dissertation met these multiple research questions through an extensive study of relevant literature and the implementation of practical research. The practical research was carried out through a three-pronged Case Study approach which included a sample product case review from one multinational company, a qualitative questionnaire with one multinational company’s senior regulatory leaders and a qualitative/quantitative questionnaire with Regulatory and Quality professionals from numerous companies. This research produced a number of key findings. The combination of the size of the Chinese market and the projected increased demand for medical devices has positioned China as a critical market for a medical device company to gain access. The survey confirmed the understanding of the importance in accessing the Chinese market. There are however challenges with the new regulations which were implemented as per CFDA’s Order 650 issued in 2014. As per the literature review and practical research one key challenge to registration is echoed repeatedly, this is the requirement for local Clinical Trials. If a clinical trial is required it will bring increased timelines, cost and resourcing to access the market in China. Understanding the Requirements, Submission & Deficiency Process, Country of Origin, Approval Timelines, Clinical Evaluation, China Specific Standards and Change Control were all also identified as key challenges to product registration. All these factors accumulate in long

Regulation Challenge of Tissue Engineering and Regenerative Medicine in China

Regulatory Oversight of Cell Therapy in China: Government's Efforts in Patient Access and Therapeutic Innovation.

[Supervision, Administration and Standard Research Related to Tissue Engineered Medical Products].

Regenerative Medicine in China: Main Progress in Different Fields

Regenerative Medicine in China: The Capacity, Capability and Reliability

[Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A]

Ethical issues and countermeasures of stem cell research in China

Study of regenerative medicine in China: demands and clinical translation

Progress and Prospect of Technical and Regulatory Challenges on Tissue-Engineered Cartilage As Therapeutic Combination Product

Advancing medical device regulatory reforms for innovation, translation and industry development in China

Standardization and Supervision of Tissue Engineered Medical Products in China

Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China

Stem Cell Based Products in Europe and in China: Where Are We and Where Should We Go?

An analysis of medical device registration and market access in China

Clinical Translation of Autologous Cell-Based Tissue Engineering Techniques As Class III Therapeutics in China: Taking Cartilage Tissue Engineering As an Example

Balancing the customization and standardization: exploration and layout surrounding the regulation of the growing field of 3D-printed medical devices in China

The Current Problems of Regulation of Medical Devices and Countermeasures

Similarities and Discrepancies of Medical Devices Regulation Between China and United States of America

The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards

A study of medical device regulation management model in Asia

Strategic Research on the Industrial Development of Innovative Technology in Cell Technology-Related Regenerative Medicine in China